logo

Sequent Scientific Ltd. Financials

15:47 Jun 18

Sequent Scientific Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
193.96
-0.77 (-0.40%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Sequent Scientific Ltd. Financials

Sequent Scientific Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
193.96
-0.77 (-0.40%)
15:47 Jun 18
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

51/100
Technically Neutral

Strength

13

Weakness

3

Opportunity

1

Threats

0

3.10 %

ROE %

1.36 %

ROA %

1.14

EPS

28.14

BVPS

1.41 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1361.62 1412.82 1420.91 1369.73 1551.37
Operating Expenses +
1149.55 1303.43 1408.95 1308.31 1389.58
Raw Material
733.68 842.41 814.87 789.21 829.94
Increase Decrease in Cost
-39.03 -49.42 18.9 -29.46 -18.09
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
187.22 231.37 258.38 250.57 281.12
Miscellaneous Expenses
557.72 622.85 560.34 649.07 721.75
Operating Profit
212.07 109.39 11.96 61.42 161.79
Other Income
8.36 10.84 6.39 10.96 14.69
Depreciation
50.6 51.08 55.69 61.54 66.45
Interest
24.38 15.77 35.52 48.09 60.75
Profit before tax and exceptio..
145.45 53.39 -72.86 -37.26 49.28
Exceptional Items
-8.82 0 -64.79 -17.39 -4.97
PBT
136.63 53.39 -137.66 -54.65 44.31
Provision for Taxation
32.18 8.33 -15.68 -25.03 12.05
Net Profit
104.45 45.06 -121.98 -29.61 32.26
NET Profit after MI
95.44 41.25 -121.16 -35.87 21.88
EPS
3.85 1.65 -4.88 -1.44 0.85
Operating Profit Margin (%)
15.57 7.74 0.84 4.48 10.43
Net Profit Margin (%)
7.01 2.92 -8.53 -2.62 1.41

Sequent Scientific Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 52.60 52.60 52.80 52.80 52.80
FII 6.00 6.10 6.40 5.70 6.20
MF 10.20 9.60 7.40 5.70 5.20
Others 2.70 2.40 2.60 2.40 2.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: